Copyright Reports & Markets. All rights reserved.

Global Facial Injectors Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Facial Injectors Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Facial Injectors Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Facial Injectors Market Size Growth Rate by Type
    • 1.4.2 Dermal Fillers/Injectable Implants (Hyaluronic Acid, Collagen Fillers and Synthetic Fillers)
    • 1.4.3 Anti-Aging/Anti-Wrinkle Injections (Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Microparticles)
  • 1.5 Market by Application
    • 1.5.1 Global Facial Injectors Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Dermatology Clinics
    • 1.5.4 Beauty Clinics
    • 1.5.5 Dermatology Research Institutes
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Facial Injectors Market Size, Estimates and Forecasts
    • 2.1.1 Global Facial Injectors Revenue 2015-2026
    • 2.1.2 Global Facial Injectors Sales 2015-2026
  • 2.2 Global Facial Injectors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Facial Injectors Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Facial Injectors Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Facial Injectors Competitor Landscape by Players

  • 3.1 Facial Injectors Sales by Manufacturers
    • 3.1.1 Facial Injectors Sales by Manufacturers (2015-2020)
    • 3.1.2 Facial Injectors Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Facial Injectors Revenue by Manufacturers
    • 3.2.1 Facial Injectors Revenue by Manufacturers (2015-2020)
    • 3.2.2 Facial Injectors Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Facial Injectors Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Facial Injectors Revenue in 2019
    • 3.2.5 Global Facial Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Facial Injectors Price by Manufacturers
  • 3.4 Facial Injectors Manufacturing Base Distribution, Product Types
    • 3.4.1 Facial Injectors Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Facial Injectors Product Type
    • 3.4.3 Date of International Manufacturers Enter into Facial Injectors Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Facial Injectors Market Size by Type (2015-2020)
    • 4.1.1 Global Facial Injectors Sales by Type (2015-2020)
    • 4.1.2 Global Facial Injectors Revenue by Type (2015-2020)
    • 4.1.3 Facial Injectors Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Facial Injectors Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Facial Injectors Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Facial Injectors Revenue Forecast by Type (2021-2026)
    • 4.2.3 Facial Injectors Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Facial Injectors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Facial Injectors Market Size by Application (2015-2020)
    • 5.1.1 Global Facial Injectors Sales by Application (2015-2020)
    • 5.1.2 Global Facial Injectors Revenue by Application (2015-2020)
    • 5.1.3 Facial Injectors Price by Application (2015-2020)
  • 5.2 Facial Injectors Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Facial Injectors Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Facial Injectors Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Facial Injectors Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Facial Injectors by Country
    • 6.1.1 North America Facial Injectors Sales by Country
    • 6.1.2 North America Facial Injectors Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Facial Injectors Market Facts & Figures by Type
  • 6.3 North America Facial Injectors Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Facial Injectors by Country
    • 7.1.1 Europe Facial Injectors Sales by Country
    • 7.1.2 Europe Facial Injectors Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Facial Injectors Market Facts & Figures by Type
  • 7.3 Europe Facial Injectors Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Facial Injectors by Region
    • 8.1.1 Asia Pacific Facial Injectors Sales by Region
    • 8.1.2 Asia Pacific Facial Injectors Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Facial Injectors Market Facts & Figures by Type
  • 8.3 Asia Pacific Facial Injectors Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Facial Injectors by Country
    • 9.1.1 Latin America Facial Injectors Sales by Country
    • 9.1.2 Latin America Facial Injectors Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Facial Injectors Market Facts & Figures by Type
  • 9.3 Central & South America Facial Injectors Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Facial Injectors by Country
    • 10.1.1 Middle East and Africa Facial Injectors Sales by Country
    • 10.1.2 Middle East and Africa Facial Injectors Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Facial Injectors Market Facts & Figures by Type
  • 10.3 Middle East and Africa Facial Injectors Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Allergan plc
    • 11.1.1 Allergan plc Corporation Information
    • 11.1.2 Allergan plc Description and Business Overview
    • 11.1.3 Allergan plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Allergan plc Facial Injectors Products Offered
    • 11.1.5 Allergan plc Related Developments
  • 11.2 GALDERMA INDIA Pvt. Ltd
    • 11.2.1 GALDERMA INDIA Pvt. Ltd Corporation Information
    • 11.2.2 GALDERMA INDIA Pvt. Ltd Description and Business Overview
    • 11.2.3 GALDERMA INDIA Pvt. Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 GALDERMA INDIA Pvt. Ltd Facial Injectors Products Offered
    • 11.2.5 GALDERMA INDIA Pvt. Ltd Related Developments
  • 11.3 Revance Therapeutics, Inc
    • 11.3.1 Revance Therapeutics, Inc Corporation Information
    • 11.3.2 Revance Therapeutics, Inc Description and Business Overview
    • 11.3.3 Revance Therapeutics, Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Revance Therapeutics, Inc Facial Injectors Products Offered
    • 11.3.5 Revance Therapeutics, Inc Related Developments
  • 11.4 Cynosure India Private Limited
    • 11.4.1 Cynosure India Private Limited Corporation Information
    • 11.4.2 Cynosure India Private Limited Description and Business Overview
    • 11.4.3 Cynosure India Private Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Cynosure India Private Limited Facial Injectors Products Offered
    • 11.4.5 Cynosure India Private Limited Related Developments
  • 11.5 Sinclair Pharma
    • 11.5.1 Sinclair Pharma Corporation Information
    • 11.5.2 Sinclair Pharma Description and Business Overview
    • 11.5.3 Sinclair Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Sinclair Pharma Facial Injectors Products Offered
    • 11.5.5 Sinclair Pharma Related Developments
  • 11.6 Merck KGaA
    • 11.6.1 Merck KGaA Corporation Information
    • 11.6.2 Merck KGaA Description and Business Overview
    • 11.6.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Merck KGaA Facial Injectors Products Offered
    • 11.6.5 Merck KGaA Related Developments
  • 11.7 Ipsen
    • 11.7.1 Ipsen Corporation Information
    • 11.7.2 Ipsen Description and Business Overview
    • 11.7.3 Ipsen Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Ipsen Facial Injectors Products Offered
    • 11.7.5 Ipsen Related Developments
  • 11.8 Valeant Pharmaceuticals International, Inc
    • 11.8.1 Valeant Pharmaceuticals International, Inc Corporation Information
    • 11.8.2 Valeant Pharmaceuticals International, Inc Description and Business Overview
    • 11.8.3 Valeant Pharmaceuticals International, Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Valeant Pharmaceuticals International, Inc Facial Injectors Products Offered
    • 11.8.5 Valeant Pharmaceuticals International, Inc Related Developments
  • 11.1 Allergan plc
    • 11.1.1 Allergan plc Corporation Information
    • 11.1.2 Allergan plc Description and Business Overview
    • 11.1.3 Allergan plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Allergan plc Facial Injectors Products Offered
    • 11.1.5 Allergan plc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Facial Injectors Market Estimates and Projections by Region
    • 12.1.1 Global Facial Injectors Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Facial Injectors Revenue Forecast by Regions 2021-2026
  • 12.2 North America Facial Injectors Market Size Forecast (2021-2026)
    • 12.2.1 North America: Facial Injectors Sales Forecast (2021-2026)
    • 12.2.2 North America: Facial Injectors Revenue Forecast (2021-2026)
    • 12.2.3 North America: Facial Injectors Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Facial Injectors Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Facial Injectors Sales Forecast (2021-2026)
    • 12.3.2 Europe: Facial Injectors Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Facial Injectors Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Facial Injectors Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Facial Injectors Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Facial Injectors Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Facial Injectors Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Facial Injectors Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Facial Injectors Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Facial Injectors Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Facial Injectors Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Facial Injectors Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Facial Injectors Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Facial Injectors Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Facial Injectors Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Facial Injectors Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Facial Injectors Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Facial Injectors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Facial Injectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Facial Injectors market is segmented into
    Dermal Fillers/Injectable Implants (Hyaluronic Acid, Collagen Fillers and Synthetic Fillers)
    Anti-Aging/Anti-Wrinkle Injections (Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Microparticles)

    Segment by Application, the Facial Injectors market is segmented into
    Hospitals
    Dermatology Clinics
    Beauty Clinics
    Dermatology Research Institutes

    Regional and Country-level Analysis
    The Facial Injectors market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Facial Injectors market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Facial Injectors Market Share Analysis
    Facial Injectors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Facial Injectors business, the date to enter into the Facial Injectors market, Facial Injectors product introduction, recent developments, etc.

    The major vendors covered:
    Allergan plc
    GALDERMA INDIA Pvt. Ltd
    Revance Therapeutics, Inc
    Cynosure India Private Limited
    Sinclair Pharma
    Merck KGaA
    Ipsen
    Valeant Pharmaceuticals International, Inc

    Buy now